TMC is a global clinical research organisation dedicated to supporting the progression of life-saving drug development solutions for rare conditions and diseases that are often neglected.

Rare diseases affect less than 65 per 100,000 people*. These people are often overlooked as smaller patient populations create significant challenges in the design and execution of clinical studies for new therapeutics.

We understand these innate challenges — working with small-to-medium biotech and biopharmaceutical companies to bring treatments for rare disorders and diseases to the market. We achieve this through our flexible, integrated and tailored services that span regulatory, pharmacovigilance, quality and combined medical services, as well as clinical governance and development phases.

*Source: The World Health Organization (WHO)

Have you heard our new

RARE CONVERSATIONS PODCAST?

The future of the rare disease landscape with our CEO, Simon Estcourt

A message from our CEO

Simon Estcourt

This is an exciting time to be involved in rare disease research. I see a future full of opportunity and hope for people living with a rare disease thanks to increased awareness from healthcare and regulatory bodies, greater support for the industry in developing effective treatments and the growth of patient advocacy groups. The implementation of more hybrid approaches is also making clinical trials significantly more accessible for patients.

In this rapidly evolving landscape, TMC’s role as a specialist CRO is more crucial than ever. The work we do throughout the drug discovery and development life cycle, working in close partnership with our clients, is pivotal in supporting the development of innovative treatments that will, ultimately, improve the quality of life for individuals worldwide.

We’re a people-driven, patient-focused company, committed to finding and implementing solutions that support the progression of life-saving treatments for rare conditions and diseases that are often neglected. Together, we’ll continue to push boundaries, creatively solve problems and embrace the opportunity to make a lasting, positive impact — for patients and their families.

You can hear more about my thoughts on the future of the rare disease landscape and why a CRO is so valuable in our new podcast.

The perfect FIT

We’re people-driven, patient focused and proud of our philosophy of providing a service that’s Flexible, Integrated and Tailored — with a focus on achieving the best possible outcomes for our clients and their patients.

Because every person matters.

Flexible

Flexible model.

We’ve developed a close bond with our global network of trusted, knowledgeable and highly skilled associates, many of whom we’ve worked with since TMC was founded in 2001! Together with our in-house team of experts, they each bring at least 15 years’ worth of experience to every project. These relationships enable us to adapt our business model to fit your unique needs and ensure the swift deployment of resources to efficiently and cost-effectively drive your drug discovery and clinical development programmes.

Integrated

Integrated approach.

We never forget that the successful launch of a rare disease drug will transform patients’ (and their loved ones’) lives. We’re truly at our best when we collaborate — and that’s why our people are your people. We support you every step of the way during the project journey, working together to set up the stages of your drug development programme on the path to success and ensure we achieve the best possible outcomes for you and your patients.

Tailored

Tailored solutions. 

No two drug discovery and development programmes are the same — just as no two patients are the same. We help you understand each patient journey and focus on your specific project needs, providing tailored solutions that facilitate your unique drug development process to bring treatments for rare disorders and diseases to market quickly, efficiently and cost-effectively.

Flexible

Flexible model.

We’ve developed a close bond with our global network of trusted, knowledgeable and highly skilled associates, many of whom we’ve worked with since TMC was founded in 2001! Together with our in-house team of experts, they each bring at least 15 years’ worth of experience to every project. These relationships enable us to adapt our business model to fit your unique needs and ensure the swift deployment of resources to efficiently and cost-effectively drive your drug discovery and clinical development programmes.

Integrated

Integrated approach.

We never forget that the successful launch of a rare disease drug will transform patients’ (and their loved ones’) lives. We’re truly at our best when we collaborate — and that’s why our people are your people. We support you every step of the way during the project journey, working together to set up the stages of your drug development programme on the path to success and ensure we achieve the best possible outcomes for you and your patients.

Tailored

Tailored solutions. 

No two drug discovery and development programmes are the same — just as no two patients are the same. We help you understand each patient journey and focus on your specific project needs, providing tailored solutions that facilitate your unique drug development process to bring treatments for rare disorders and diseases to market quickly, efficiently and cost-effectively.

Milestones in numbers

Championing patients living with rare conditions and diseases…

0 years
since TMC was founded
0+
associates worldwide
0+
paediatric investigation plans (PIP)
0+
orphan drug designation (ODD) applications